Fund detail
Jennison Associates
large-active, growth, lo
Quarters
52
2017-03-31
$93.20B
Positions
628
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KITE PHARMA INC | $48.9M | 0.05% | 622,607 | +0 | +0.00% | 0.03% | 2014-09-30 | $78 | ~$48 | +63.52% | |
| 2 | TESARO INC T8S | $37.0M | 0.04% | 240,219 | +0 | +0.00% | 0.04% | 2013-06-30 | $154 | ~$44 | +251.97% | |
| 3 | ULTRAGENYX PHARMACEUTICAL IN RARE | $33.9M | 0.04% | 500,290 | +0 | +0.00% | 0.04% | 2014-03-31 | $68 | ~$57 | +19.85% | |
| 4 | EPIZYME INC EPZMEUR | $33.2M | 0.04% | 1,933,804 | +0 | +0.00% | 0.03% | 2015-03-31 | $17 | ~$14 | +18.39% | |
| 5 | OCULAR THERAPEUTIX INC OCUL | $29.9M | 0.03% | 3,216,881 | +0 | +0.00% | 0.03% | 2015-03-31 | $9 | ~$13 | -30.03% | |
| 6 | PROTHENA CORP PLC | $22.9M | 0.02% | 409,582 | +0 | +0.00% | 0.02% | 2013-06-30 | $56 | ~$20 | +183.68% | |
| 7 | SAREPTA THERAPEUTICS INC SRPT | $16.7M | 0.02% | 563,333 | +0 | +0.00% | 0.02% | 2014-09-30 | $30 | ~$32 | -6.42% | |
| 8 | AVEXIS INC | $14.0M | 0.01% | 183,786 | +0 | +0.00% | 0.01% | 2016-03-31 | $76 | ~$28 | +176.21% | |
| 9 | DOMINION MIDSTREAM PARTNERS | $13.0M | 0.01% | 407,074 | +0 | +0.00% | 0.01% | 2014-12-31 | $32 | ~$38 | -16.53% | |
| 10 | PROQR THRAPEUTICS N V | $12.9M | 0.01% | 2,585,047 | +0 | +0.00% | 0.01% | 2014-09-30 | $5 | ~$11 | -55.70% | |
| 11 | AGIOS PHARMACEUTICALS INC AGIO | $9.9M | 0.01% | 169,799 | +0 | +0.00% | 0.01% | 2013-09-30 | $58 | ~$53 | +9.93% | |
| 12 | TABULA RASA HEALTHCARE INC TRHCEUR | $5.5M | 0.01% | 405,194 | +0 | +0.00% | 0.01% | 2016-09-30 | $13 | ~$14 | -6.59% | |
| 13 | AUDENTES THERAPEUTICS INC BOLDEUR | $5.1M | 0.01% | 299,656 | +0 | +0.00% | 0.01% | 2016-09-30 | $17 | ~$18 | -4.33% | |
| 14 | RA PHARMACEUTICALS INC RARXEUR | $4.3M | 0.00% | 202,500 | +0 | +0.00% | 0.00% | 2016-12-31 | $21 | ~$15 | +40.15% | |
| 15 | OVASCIENCE INC | $4.1M | 0.00% | 2,183,527 | +0 | +0.00% | 0.00% | 2014-03-31 | $2 | ~$26 | -92.70% | |
| 16 | MACROGENICS INC MGNX | $3.5M | 0.00% | 188,908 | +0 | +0.00% | 0.00% | 2013-12-31 | $19 | ~$29 | -35.74% | |
| 17 | NORTHERN DYNASTY MINERALS LT NAK | $2.5M | 0.00% | 1,763,422 | +0 | +0.00% | 0.00% | 2013-06-30 | $1 | ~$2 | -31.58% | |
| 18 | WAVE LIFE SCIENCES LTD | $2.1M | 0.00% | 75,435 | +0 | +0.00% | 0.00% | 2015-12-31 | $27 | ~$16 | +75.90% | |
| 19 | STEADYMED LTD | $2.1M | 0.00% | 355,660 | +0 | +0.00% | 0.00% | 2015-03-31 | $6 | ~$8 | -31.33% | |
| 20 | ADURO BIOTECH INC ADROEUR | $907K | 0.00% | 84,350 | +0 | +0.00% | 0.00% | 2015-06-30 | $11 | ~$29 | -62.56% | |
| 21 | ARBUTUS BIOPHARMA CORP ABUS | $455K | 0.00% | 140,019 | +0 | +0.00% | 0.00% | 2016-12-31 | $3 | ~$2 | +32.65% |